Prostate Cancer (Adenocarcinoma)
Oncology
0
Pipeline Programs
3
Companies
3
Clinical Trials
3 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
EXACT TherapeuticsNorway - Oslo
1 program6 month, prospective, interventional single-arm safety and effectiveness studyN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2025
2026
2027
2028
AM-Pharmapreop virtual 3D model
Blue Earth TherapeuticsPositron Emission Tomography
EXACT Therapeutics6 month, prospective, interventional single-arm safety and effectiveness study
Clinical Trials (3)
Total enrollment: 7 patients across 3 trials
Navigation, Outcomes and Quality-of-life in Prostate Cancer Patients Undergoing PSMA-targeted Surgery
Start: Jan 2026Est. completion: Dec 2028
N/ARecruiting
Flotufolastat F 18 PET in Men With Very Low PSA Recurrence
Start: May 2025Est. completion: Dec 2026
N/ARecruiting
NCT07339943EXACT Therapeutics6 month, prospective, interventional single-arm safety and effectiveness study
Micro-ultrasound-Guided Focal Laser Ablation for Intermediate-Risk Prostate Cancer: Safety & Effectiveness
Start: Apr 2025Est. completion: Dec 20277 patients
N/ARecruiting
Related Jobs in Oncology
Cell Therapy Account Manager(北陸)
Gilead Sciences
Japan - Tokyo
Just now
Leo Cancer Care: Senior In-House Counsel/General Counsel
Leo Cancer Care
Middleton, Wisconsin
5h ago
Summer Intern - Computational Chemistry & Artificial Intelligence
Arvinas
Remote
7h ago
Executive Medical Director, Oncology Early Development
AbbVie
Florham Park, NJ
8h ago
Executive Medical Director, Oncology Early Development
AbbVie
South San Francisco, CA
8h ago
Executive Medical Director, Oncology Early Development
AbbVie
North Chicago, IL
8h ago
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
3 actively recruiting trials targeting 7 patients
3 companies competing in this space